• News & Blog

Featured: Investments

Novus portfolio company TC BioPharm signs US collaboration deal.

Scottish life sciences group TC BioPharm (TCB) secures a $16 million (£12 million) strategic collaboration with US bio-tech group Bluebird to discover and develop new cancer treatments.


Author: Clive Gunther

Featured: Company news

Novus Investments is delighted to be appointed an Inspire Partner

We are delighted that Novus’s unique SME business offering has been recognised and engaged by Inspire the Business Growth Network by Wessex Chambers. This now gives Inspire the...


Author: Clive Gunther